Recall round-up: CBD oil, infant formula & salmon oil + vit D3 supplement

By Will Chu

- Last updated on GMT

Recall round-up: CBD oil, infant formula & vit D3 supplement

Related tags recall Fsai notice

After the Summer recess, NutraIngredients returns for its monthly recall round-up, where September brings news of food alerts involving CBD oils, children’s food supplements and fish oil-based capsules.
CBD One Label

The Food Safety Authority of Ireland (FSAI) has notified consumers​ not to consume cannabidiol (CBD) oil from UK-based retailer CBD One after inspectors found traces of delta‐9‐tetrahydrocannabinol (THC) in one batch.

While the authorities stress that there are no immediate dangers associated with the consumption of the product, they point out the batch contains unsafe levels of THC based on the European Food Safety Authority (EFSA) acute reference dose.

The affected batches concern pack sizes of 10 millilitres (ml) and contains the code ‘1/19/154-250’ with a best before date of ‘10-2020.’ The batches’ country of origin is Netherlands.

Distributors are advised to withdraw the product from the market, whilst retailers are requested to remove the products from sale.

Super Hair Food Supplement

Super hair food supplement

Also flagged up by the FSAI is a notice​by Holland & Barrett (H&B) who are recalling batches of Super Hair Food Supplement due to the presence of soya protein that is not declared on the label. 

This may make the implicated batches unsafe for consumers who are allergic to or intolerant of soya.

Affected batches of H&B’s Super Hair Food Supplement are labelled with the best before end dates of  ‘February and March 2023.’

These coated tablets, which are a ‘1 a day’ formula are available in pack sizes of 60 tablets are contain the batch codes, ‘751519-01, 751519-03, 751944-01 and 751949-03.’ No other packs are known to be affected.

Anti-Reflux formula recall

Hipp Anti Reflux

The FSAI also highlight a notice​ by infant nutrition specialists HiPP UK Ltd, who are recalling a batch of its Anti-Reflux formula.

This is due to thickening issues when reconstituted and is therefore ineffective at helping babies with reflux and regurgitation. 

“Only packs made between 14.49 and 15.46 (production time is marked on the bottom of the packet, with the batch code) are affected,”​ the recall notice states.

“Point-of-sale recall notices will be displayed in the shops where the implicated batch was sold, which were the Boots chain of shops.”

Kid’s food supplement

Meanwhile over in the Czech Republic, the country’s Agriculture and Food Inspection Authority (CAFIA) has withdrawn a children’s food supplement from retail after labelling omits the presence of milk protein.

The product, ‘Infants Dophilus Plus (Probiotic complex for children, recommended from 4th month; 7 probiotic cultures, 6 billion viable bacteria in 1g), has the lot number, ‘50TC045’ and a use by date of ‘15. 4. 2021,’ While the product’s producer is not stated, its country of origin is Canada.

Kid's food supplement

“Analysis carried out in the CAFIA laboratory confirmed presence of milk protein amounting to 5,412 milligrams per kilogram (mg/kg),”​ the recall notice​ states. “The foodstuff is unsafe for persons suffering from allergy or intolerance to the allergen in question.”

The analysis also detected another potential allergen lactose amounting to 2,500 mg/kg, despite the label stating otherwise.

“The foodstuff cannot be regarded as safe,” ​says CAFIA inspectors, who ordered the seller, TAINEX to immediately withdraw the lot in question from its website​.

Additional information on the labelling, identifies the Prague-based company Pharma Agency company as the importer of the foodstuff into the Czech Republic.

Salmon Oil + vit D3 supplement

Cardio Salmon oil

Finally, The Norwegian Food Safety Authority have ordered​ Hofseth BioCare to withdraw its Cardio Salmon Oil + D3», dietary supplements (capsules), due to a vitamin D3 content that exceeds that stated on the label.

The capsules, which have a best before date, ‘18.11.2022,’ and ‘23.03.2023,’ and a Batch/Lot no of ‘B0012480’ and ‘B0017443,’ were sold from the firm’s online store​.

So far 426 boxes of the dietary supplement have been sold mainly to corporate customers. The firm has said the product has been withdrawn and is no longer available in the online store. They advise consumers to dispose of the product and contact them for a refund.

“The capsules contain more vitamin D than what is stated on the label,”​ the recall notice states. “This means that the recommended daily dose of the product exceeds the permitted maximum content for vitamin D in dietary supplements in Norway.

“Hofseth Biocare considers the health risk to be low for the period of time that consumers may have ingested the capsules. The risk increases with consumption over time, since vitamin D accumulates in the body.”

Related news

Show more

Related products

show more

Whitepaper: Discover a new era in postbiotics

Whitepaper: Discover a new era in postbiotics

Content provided by DSM Nutritional Products | 28-Nov-2023 | White Paper

Postbiotic ingredients are set to open up a world of opportunities across the human health and nutrition industry, fueled by developing science demonstrating...

Taking Immune Support to a New Level

Taking Immune Support to a New Level

Content provided by AB Biotek Human Nutrition & Health | 30-Oct-2023 | White Paper

Patent-pending ABB C1® redefines immune support by addressing innate, acquired, and Trained Immunity. In 'ABB C1®: Training Now for Future Immune...

Related suppliers

Follow us


View more